100-fold reduction of virus: S. Korea pharma company reports progress in experimental COVID-19 drug

  • 📰 ANCALERTS
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 50%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

100-fold reduction of virus: S. Korea pharma company reports progress in experimental COVID19 drug

SEOUL - South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.

The pre-clinical study of the drug showed improved recovery in runny nose, cough and body aches after the first day of treatment, and clearing of lung inflammation within six days, the company said in a statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

A ray of hope in the struggle against the SARS-CoV-2 virus...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 26. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines